65
Participants
Start Date
November 25, 2014
Primary Completion Date
November 30, 2023
Study Completion Date
November 30, 2038
Patient Derived CD171 specific CAR T cells expressing EGFRt (2nd generation T cells)
Intravenous infusion of autologous T cells transduced to express 4-1BB:zeta CD171CAR and EGFRt (2nd generation T cells)
Patient Derived CD171 specific CAR T cells expressing EGFRt (3rd generation T cells)
Intravenous infusion of autologous T cells transduced to express CD28:4-1BB:zeta CD171CAR and EGFRt
Patient Derived CD171 specific CAR T cells expressing EGFRt (long spacer 2nd generation T cells)
Intravenous infusion of autologous T cells transduced to express 4-1BB:zeta CD171CAR and EGFRt (long spacer 2nd generation T cells)
Seattle Children's Hospital, Seattle
The Evan Foundation
OTHER
Ben Towne Center for Childhood Cancer Research
OTHER
Seattle Children's Hospital
OTHER